Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01406990
Other study ID # 11-16154
Secondary ID
Status Completed
Phase N/A
First received July 13, 2011
Last updated August 28, 2012
Start date June 2011
Est. completion date April 2012

Study information

Verified date August 2012
Source Creighton University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

The purpose of this study is to measure the percentage of women with known Coronary Artery Disease (CAD) who are hyporesponsive to low dose (81 mg) aspirin.


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date April 2012
Est. primary completion date April 2012
Accepts healthy volunteers No
Gender Female
Age group 45 Years to 85 Years
Eligibility Inclusion Criteria:

- Able and willing to provide informed consent

- Women at least 45 years old of any race

- Taking 81 mg aspirin daily, for at least one month

- Diagnosed with known or suspected CAD with at least one of the following: angiographic evidence of at least one lesion > 50% stenosis, history of significant elevation of biomarker troponin or CK-MB, or history of ECG changes in at least 2 contiguous leads characterized by either new ST depression > 0.1 mV or transient (<30 min) ST elevation > 0.1 mV, coronary artery revascularization either by PCI or CABG

Exclusion Criteria:

- < 45 years or > 85 years of age

- Clinically unstable: hypotension defined as sustained systolic blood pressure of <90 mmHg due to cardiac failure with associated symptoms, unstable or severe pulmonary edema, decompensated congestive heart failure, acute mitral regurgitation, acute ventricular septal defect, acute cerebrovascular event or transient ischemic attack (TIA) within the past six months, history of ventricular fibrillation and no implantable cardioverter defibrillator (ICD), sustained supraventricular tachycardia > 30 seconds or associated with symptoms and no ICD, untreated complete heart block or untreated high grade secondary heart block

- Pregnant, planning to become pregnant, or breastfeeding

- Alcohol abuse or illicit drug abuse

- Allergy or intolerance to salicylates and/or excipients including a history of and/or active GI bleed

- Use of NSAIDs within seven days or planned regular use during the study

- Taking HRT or oral contraceptives within the past 30 days or planned use during study

- Use of heparin, warfarin, ADP inhibitors (clopidogrel, prasugrel, or ticlopidine), or glycoprotein IIb/IIa inhibitors within previous 96 hours or planned use during the study

- Use or planned use of any other medications known to interfere with AA-induced platelet function

- Currently participating in another investigational drug or device study

- Survival less than six months

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Locations

Country Name City State
United States The Cardiac Center at Creighton University Omaha Nebraska

Sponsors (1)

Lead Sponsor Collaborator
Creighton University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Women With Known CAD Who Are Hyporesponsive to Low Dose (81 mg) Aspirin Hyporesponsive was defined as Aspirin Response Unit (ARU) > 550 equating to less than 50% platelet inhibition. Time of enrollment No
See also
  Status Clinical Trial Phase
Terminated NCT04459299 - CorPath GRX STEMI Study
Not yet recruiting NCT02853994 - Safety and Efficacy of the DEVOIR Sirolimus-Coated Coronary Balloon in the Real-world Clinical Practice N/A
Completed NCT02440893 - Understanding the Effect of Metformin on Corus CAD (or ASGES)
Completed NCT01486030 - Effect of Exercise Stress Testing on Peripheral Gene Expression Using Corus CAD (or ASGES) Diagnostic Test
Recruiting NCT06239493 - IVUS-Guided Treatment for Percutaneous Vascular Interventions
Recruiting NCT05344612 - Comparing a Diagnostic and Treatment Strategy of Upfront CTCA With SOC in Patients With Chest Pain and Suspected CAD N/A
Terminated NCT03901079 - Trial for A Novel Facilitated Antegrade Steering Technique in Revascularization of Coronary Chronic Total Occlusions
Completed NCT02457455 - Urgent Medical and Surgical Conditions During Flights N/A
Recruiting NCT05509010 - AI Driven National Platform for CT cOronary Angiography for clinicaL and industriaL applicatiOns Registry
Completed NCT03930589 - Remote Ischemic Conditioning in STEMI to Decrease Infarct Size N/A
Completed NCT01251302 - Utility of a Molecular Personalized Coronary Gene Expression Test (Corus CAD or ASGES) on Cardiology Practice Pattern
Withdrawn NCT02158754 - Clinician Utilization of Corus CAD (or ASGES) in Primary Care Provider Decision Making
Completed NCT01949844 - Artifact-Free High-Resolution Myocardial Perfusion MRI in Subjects With Abnormal Nuclear Myocardial Perfusion Studies N/A
Recruiting NCT04787796 - The Application of a Portable Multichannel ECG System for the Patients Suspected to Have Possible CAD or ACS N/A
Recruiting NCT03894423 - Comprehensive Computed Tomography Guidance of Coronary Bypass Graft Surgery
Completed NCT02223286 - Understanding Clinician Utilization of Corus CAD (Age/Sex/Gene Expression Score - ASGES) in Clinical Decision Making N/A
Completed NCT06154018 - Heparin Reversal With Two Different Protamine Ratios After Cardiopulmonary By-pass. N/A
Completed NCT02132611 - Coronary Orbital Atherectomy System Study N/A
Completed NCT01402804 - NSAIDs in Coronary Artery Disease Patients N/A
Completed NCT00500617 - Personalized Risk Evaluation and Diagnosis (Using Corus CAD or ASGES) in the Coronary Tree